Shandong Wohua Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001QB8
CNY
6.20
-0.21 (-3.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
807.07
750.89
894.31
1,001.83
926.54
993.79
849.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
807.07
750.89
894.31
1,001.83
926.54
993.79
849.47
Raw Material Cost
209.01
217.89
241.44
261.63
222.07
229.30
205.69
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.10
0.07
0.13
0.13
5.97
5.98
1.53
Selling and Distribution Expenses
463.30
458.30
560.95
582.59
464.92
505.56
486.21
Other Expenses
3.54
3.91
4.32
4.74
3.89
3.81
4.84
Total Expenditure (Excl Depreciation)
707.78
715.40
845.68
891.74
731.90
778.94
741.86
Operating Profit (PBDIT) excl Other Income
99.3
35.5
48.6
110.1
194.60000000000002
214.8
107.6
Other Income
10.89
8.67
8.57
10.09
17.87
21.62
10.62
Operating Profit (PBDIT)
134.55
75.32
88.13
146.51
243.03
256.34
130.89
Interest
0.10
0.07
0.13
0.13
5.97
5.98
1.53
Exceptional Items
-1.29
-0.13
-0.14
-0.26
-14.06
-1.75
2.14
Gross Profit (PBDT)
598.06
533.00
652.88
740.20
704.47
764.49
643.78
Depreciation
30.78
32.47
33.22
35.33
33.05
28.17
18.58
Profit Before Tax
102.38
42.65
54.64
110.79
189.96
220.45
112.92
Tax
13.59
8.89
8.01
20.91
28.63
34.13
15.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
95.72
36.40
58.77
107.39
163.39
178.88
95.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
95.72
36.40
58.77
107.39
163.39
178.88
95.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-6.92
-2.64
-12.14
-17.50
-2.07
7.44
1.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
88.79
33.76
46.63
89.89
161.32
186.32
97.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
723.82
697.37
805.27
746.50
820.72
807.40
671.98
Earnings per share (EPS)
0.17
0.06
0.1
0.19
0.28
0.31
0.17
Diluted Earnings per share
0.17
0.06
0.1
0.19
0.28
0.31
0.17
Operating Profit Margin (Excl OI)
11.51%
4.55%
5.18%
10.09%
20.73%
20.79%
11.97%
Gross Profit Margin
16.5%
10.0%
9.82%
14.59%
24.07%
25.02%
15.48%
PAT Margin
11.86%
4.85%
6.57%
10.72%
17.63%
18.0%
11.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 7.48% vs -16.03% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 162.72% vs -27.47% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 85.46% vs -16.21% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Shandong Wohua Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
807.07
0
807.07
Other Operating Income
0.00
0.00
0.00
Total Operating income
807.07
0
807.07
Raw Material Cost
209.01
0
209.01
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.10
0
0.10
Selling and Distribution Expenses
463.30
0
463.30
Other Expenses
3.54
0.00
3.54
Total Expenditure (Excl Depreciation)
707.78
0
707.78
Operating Profit (PBDIT) excl Other Income
99.29
0.00
99.29
Other Income
10.89
0
10.89
Operating Profit (PBDIT)
134.55
0
134.55
Interest
0.10
0
0.10
Exceptional Items
-1.29
0
-1.29
Gross Profit (PBDT)
598.06
0
598.06
Depreciation
30.78
0
30.78
Profit Before Tax
102.38
0
102.38
Tax
13.59
0
13.59
Provisions and contingencies
0
0
0.00
Profit After Tax
95.72
0
95.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
95.72
0
95.72
Share in Profit of Associates
0
0
0.00
Minority Interest
-6.92
0
-6.92
Other related items
0.00
0.00
0.00
Consolidated Net Profit
88.79
0
88.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
723.82
0
723.82
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
11.51%
0%
0.00
11.51%
Gross Profit Margin
16.50%
0%
0.00
16.50%
PAT Margin
11.86%
0%
0.00
11.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 80.71 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 7.48% vs -16.03% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 8.88 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 162.72% vs -27.47% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.37 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 85.46% vs -16.21% in Dec 2024

Annual - Interest
Interest 0.01 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.51%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024